Aaron Katz (Associate Professor of Clinical Urology, Columbia Medical
Center, New York), recently completed his 50th prostate cancer case utilizing
their minimally invasive 17-gauge IceRods.
Investigators presented data from 239 evaluable patients , of whom
163 patients had colorectal cancer, 32 patients had upper GI-tract
cancer, 38 patients had non-small cell lung cancer and 6 patients had
liver or bile-duct carcinoma. Twelve-month survival was 60%
for patients receiving IGN101 versus 48. The recommendation stems from the availability of
sophisticated new treatments - including stereotactic radiosurgery - for
metastatic brain tumors that are detected early.

devastating gland

He added, "My decision
to adopt ONCURA's IceRods has been vindicated by the excellent results I've
seen to date; clinical outcomes remain excellent, and the overall side effects
are extremely low. In the study, a statistically significant
difference in overall survival was seen in a subgroup of patients with
rectal cancer and a positive trend toward survival improvement was
observed in patients with colon cancer. The primary objective of the
study was to assess the effects of IGN101 on overall survival and an
exploratory analysis on subgroups of patients by indication .
Vaccinations with IGN101 or placebo were given on days 1, 15, 29 and
57 and in weeks 16, 24, 32, 40 and 68. IGN101 is intended to selectively destroy
disseminated and circulating tumor cells and thus may slow or prevent
the formation and growth of metastases. All of Elekta's
solutions employ non-invasive or minimally invasive techniques and are
therefore clinically effective, gentle on the patient and cost-effective.

tumors gland

"
"Working with Dr. Leksell Gamma Knife(R) Remains the Radiosurgery Gold Standard

ATLANTA, Neurologists now recommend regular MRI
brain scans for patients with lung, breast, and other cancers that carry a
high-risk of brain metastasis, according to an Associated Press article
released earlier this month. Up to 40 percent of lung cancer patients and 33 percent of breast
cancer patients develop these tumors. Following the acquisition of IMPAC Medical Systems Inc.

cryo retinopathy

Over the course of his career, Dr. Median
survival in rectal cancer patients was 415 days for patients receiving
IGN101, compared to 253 days for patients receiving placebo (P =
0. This information is qualified
in its entirety by cautionary statements and risk factor disclosure
contained in Aphton's Securities and Exchange Commission filings,
including Aphton 's report on Form 10-K filed with the Commission on
March 16, 2005.S. in
April 2005, the Elekta Group became the world's largest supplier of oncology
software.

It also includes therapeutic uses of LN2 for removing skin cancers, moles, and warts.

shuman tumors

edu.
ONCURA was created through the merger of Amersham plc's brachytherapy
business and Galil Medical Ltd. ONCURA's International business is operated from its UK subsidiary.

genitourinary metastases

"
Dr. His experience with this group of patients has made him a
renowned authority, treating patients from around the world.
"The therapeutic properties of the 17-gauge IceRod are exactly what I
needed to enhance the clinical approach I've developed when treating prostate
cancer with cryotherapy," said Dr. Target accrual of 760 patients has
recently been reached in this trial, three months ahead of schedule. "It
also offers the gentlest care.

minimally retinopathy

Vaccinations with
IGN101 were well tolerated."

About IGN101

IGN101 is a cancer vaccine designed to induce an immune response
against EpCAM positive tumor cells.com

Safe Harbor

Except for the factual information herein, the matters discussed
herein are forward-looking statements that involve a number of risks
and uncertainties and are not a guarantee of future performance.

retinopathy cryo

Katz is also
called upon by physicians from the US and Europe to train them in the use of
cryotherapy .

Business Editors/Health/Medical Writers

PHILADELPHIA----

Statistically Significant Survival Demonstrated in Patients with
Rectal Cancer; Survival Trend Demonstrated in Patients with
Colorectal Cancer Patients

Aphton Corporation (NASDAQ:APHT) announced today that results from
its double-blind, placebo-controlled Phase II clinical trial of its
cancer vaccine IGN101 in patients with solid tumors were presented at
the 2005 Annual Meeting of the American Society for Clinical Oncology
(ASCO) in Orlando, Florida. Analysis of 1-year survival indicated that survival doubled to
62% for patients receiving IGN101 from 29.
(Logo: http://www.

shuman tumors

Dr.'s urology business.
Leksell Gamma Knife(R) from Elekta remains the solution of choice and the
standard of care for intracranial stereotactic radiosurgery.

cryosurgery tumors

Epithelial cancers account for approximately
70 % of all cancers.

gland retinopathy

Katz is a member of the American Urological Association, the Society
of University Urologists, Society of Urologic Oncologists and the Southwest
Oncology Group.com/cgi-bin/prnh/20020318 /ELEKTALOGO )

Neurologists from the Chicago Institute of Neurosurgery and Neuroresearch
(CINN) and the University of Pittsburgh Cancer Center explained that cancer
patients are surviving longer, which increases the risk of metastatic brain
tumors.com).

retinopathy devastating

Galil is a subsidiary of
Elron (ELRN).

For the
intent-to-treat population, no difference in overall survival was
observed , however, a statistically significant survival prolongation
was observed in the 53 stage IV rectal cancer patients.newscom.

galil minimally

Dr. Katz has won numerous
awards and grants, including one from the NIH to study the molecular staging
of prostate cancer, as well as one from CaPCure for the investigation of an
antibody to prevent the recurrence of prostate cancer. A trend for prolonged survival was also observed in stage IV
colon patients during the first year. EpCAM is a cell surface glycoprotein
present in normal epithelial cells and over-expressed in the majority
of epithelial cancers.

About Aphton

Aphton Corporation, headquartered in Philadelphia, Pennsylvania is
a clinical stage biopharmaceutical company focused on developing
targeted immunotherapies for cancer.elekta.
Clinical solutions include Leksell Gamma Knife(R) for non-invasive
treatment of brain disorders and Elekta Synergy(R) for image guided radiation
therapy (IGRT).

colorectal antigen

Katz can be
contacted via email at aek4@columbia.
"The significant prolongation of survival seen in metastatic
rectal cancer patients is highly encouraging," commented Patrick
Mooney, MD, Chairman and Chief Executive Officer of Aphton
Corporation. These risk factors include,
but are not limited to: (1) any modifications to the data arising in
connection with preparing the registration of IGN101; (2) Aphton's
ability to obtain regulatory approval for IGN101 or produce IGN101 in
commercial quantities and gain commercial acceptance, (3) Aphton's
ability to fund the registration and commercialization of IGN101; (4)
intellectual property risks; (5) the impact of competitive products
and pricing; and (6) changing economic conditions .

biopsy carcinoma

PHILADELPHIA, ONCURA, a global leader in the
minimally invasive management of prostate cancer , is pleased to announce that
Dr. Katz has been an excellent education," said James
McGlone, CEO and President of ONCURA. All patients had
metastatic disease (stages III and IV). Aphton is currently seeking partners that
will support the further development of Insegia (G17DT immunogen), its
immunogen targeting the hormone gastrin. Aphton has strategic
alliances with sanofi-aventis for the development and
commercialization of Insegia related to cancers of the
gastrointestinal system and other cancers in North America and Europe;
Daiichi Pure Chemicals for the development, manufacturing and
commercialization of gastrin-related diagnostic kits; and Xoma for
developing humanized monoclonal and other antibodies to treat
gastrointestinal and other gastrin-sensitive cancers.aphton. These forward-looking statements include statements about:
(1) IGN101's ability to induce a response against EpCam positive
tumors; (2) IGN101's ability to selectively destroy disseminated and
circulating tumor cells; (3) Aphton 's belief that destroying
disseminated and circulating tumor cells may slow or prevent the
formation and growth of metastasis; (4) Aphton's intention to seek and
ability to find a partner for Insegia . Aphton undertakes
no obligation to update forward-looking statements to reflect events
or circumstances after the date hereof.
Elekta's systems and solutions are used in over 3,000 hospitals around the
world to treat cancer and to manage clinical operations as well as to diagnose
and treat brain disorders, including tumors, vascular malformations and
functional disorders.

galil cryo

ONCURA(TM) Announces That Dr. Aaron Katz of Columbia Presbyterian Has Treated Over 50 Prostate Cancer Patients With the SeedNet (TM) Cryotherapy System

Katz is
noted for his experience in using cryotherapy as an option for patients who
have previously received radiation therapy but have unfortunately seen their
cancer return.037).8% for patients receiving
placebo (p = 0.28). "We will be reviewing next steps for IGN101 in this and
other epithelial cancers and are certainly enthusiastic about the
ongoing randomized study in non small cell lung cancer, which has
recently completed accrual. In the trial, IGN 101 is
being evaluated as a monotherapy. Aphton's products seek to empower
the body's own immune system to fight disease. These
forward-looking statements may be affected by the risks and
uncertainties inherent in the drug development process and in Aphton's
business. Routine brain scans can detect these
tumors, which can be treated with drugs as well as stereotactic radiosurgery.
Among the sophisticated radiosurgery treatment options for patients at
CINN is Gamma Knife(R) surgery.

warts shuman

"Since the introduction of ONCURA's 17-gauge IceRod(TM) needles last
September I've been impressed with their ability to provide highly
controllable and effective cryotherapy," said Dr Katz. He added , "Not only have we been able
to learn so much about the clinical application of cryotherapy, we've seen a
world leader validate our minimally invasive approach to urological disease
management . Patients with melanoma, kidney cancer,
and colon cancer are also at risk.
"The combination of early detection and Gamma Knife(R) surgery provides
one of the best possible outcomes for patients who are treated via
stereotactic radiosurgery," says Jim Rose, VP Marketing, North America.

warts genitourinary

Dr . Secondary
endpoints included safety, tolerability and immunogenicity.

(for center locations , visit
http://www.

prematurity retinopathy

Through the acquisition
of Igeneon AG in March 2005, Aphton acquired late-stage products,
IGN101, a cancer vaccine designed to induce an immune response against
EpCAM positive tumor cells, and IGN311, a fully humanized antibody
against the Lewis Y antigen. For more
information about Aphton or its programs please visit Aphton's website
at http://www. Aphton wishes to caution readers that certain
important factors may have affected and could in the future affect
Aphton 's beliefs and expectations and could cause the actual results
to differ materially from those expressed in any forward-looking
statement made by or on behalf of Aphton.

prematurity biopsy

IGN101 was acquired by Aphton
through its recent acquisition of Igeneon AG, an Austrian based
biopharmaceutical company. Substantially all of the patients in the IGN101
group mounted an antibody response to the vaccine antigen.

Neurologists Recommend MRIs for Early Detection of Brain Metastases in Lung and Breast Cancer Patients Due to High Effectiveness of Radiosurgery

"
Often referred to as "the gold standard" for radiosurgery , the Leksell
Gamma Knife(R) from Elekta is the standard of care for neurosurgery, with
thousands of published papers on treatment efficacy and improved quality of
life for patients.
Gamma Knife(R) surgery is a noninvasive method for treating targets in the
brain.

prostate thoracic

He added, "The minimally invasive
approach of a 17-gauge needle, especially the IceRod, is a true advance in the
technology of cryotherapy and has had a positive impact on patient care.

genitourinary biopsy

Katz is a pioneer in the use of cryotherapy for the treatment of
prostate cancer; since 1997 he's treated over 400 patients and has over 50
peer -reviewed publications describing outstanding cure rates in respected
journals such as the Journal of Urology, Contemporary Urology, Molecular
Urology, British Journal of Urology, Cancer, and Cancer Research.
This randomized, double-blind, placebo-controlled phase II
clinical trial was conducted in 240 patients with epithelial cancers,
which consists of colorectal cancer, gastrointestinal tract cancer,
non-small cell lung cancer and liver cancer.

Cryosurgery is the medical use of liquid nitrogen (LN2) for removing tumors of the prostate gland and other organs.

retinopathy rooker

On April 8, 2004, General Electric (GE) completed its previously announced
acquisition of Amersham.

Aphton Reports Significant Activity of IGN101 in Patients with Epithelial Cancers

Use of
concomitant chemotherapy had no effect on survival. There is also a Leksell Gamma Knife(R) at the
University of Pittsburgh Medical Center.

Because the procedure is wholly noninvasive,
patients often go home the same day they receive treatment .

metastases devastating

Groups were well balanced regarding age,
sex, performance status and concomitant therapies. It delivers a single, high dose of irradiation to the precisely located
target, without harming the surrounding healthy tissue.
With approximately 1,700 employees, Elekta's corporate headquarters is
located in Stockholm, Sweden, and the company is listed on the Stockholm Stock
Exchange under the ticker EKTAb.

metastases prematurity

Katz."
Dr. Headquartered in the United States, ONCURA operates as an
independent business , with a major presence in the treatment of prostate
cancer.5% for patients receiving
placebo.

IGN101 is an off-the-shelf product
consisting of the murine anti-EpCAM monoclonal antibody 17 1-A
adsorbed on aluminum hydroxide.
A randomized, double-blind, placebo-controlled Phase II/III
clinical trial is currently being conducted with IGN 101 in patients
with advanced non-small cell lung cancer . Overall, Leksell Gamma Knife(R) is
installed at more than 100 facilities in the U.

About Elekta
Elekta is an international medical technology group, providing meaningful
clinical solutions, comprehensive information systems and services for
improved cancer care and management of brain disorders.

colorectal metastases

---

- - kjjkjk

Loading...

(Note: These pages use the Atlas Content Safeguard System (ACSS) and require that Javascript is enabled for viewing.)